Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Pharmaceutical Statistics|June 21, 2025
Further Practical Guidance on Adjusting Time-To-Event Outcomes for Treatment SwitchingClaire Watkins, Eva Kleine, Miguel Miranda, et al.
Thrombosis Journal|November 28, 2015
Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgeryChristian Wurnig, Andreas Clemens, Helmuth Rauscher, et al.
Thrombosis Journal|April 5, 2016
Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical settingNadia Rosencher, Charles M Samama, Martin Feuring, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 8, 2015
Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS2 ScoreMasatsugu Hori, Taku Fukaya, Eva Kleine, et al.
Thrombosis Research|May 23, 2016
Observational study of dabigatran etexilate 150mg in patients with moderate renal impairment undergoing elective total hip or knee replacementCharles-Marc Samama, Nadia Rosencher, Eva Kleine, et al.
Stroke|January 28, 2021
Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUSHans-Christoph Diener, Aurauma Chutinet, J Donald Easton, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 14, 2019
Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT studyStefan H Hohnloser, Hugh Calkins, Stephan Willems, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 16, 2019
Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT studyHugh Calkins, Stephan Willems, Atul Verma, et al.
Circulation|November 5, 2017
Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized TrialsNaoual Bennaghmouch, Anne J W M de Veer, Kerstin Bode, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 19, 2017
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) studyPaolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli, et al.
Pageof 3